Developing better medications for children with HIV
Official title: Expertise in Development of Pediatric Drug Formulations
Funded at Advanced Bioscience Laboratories, INC. · NIH-10927009 · Data updated 2026-11-12
This study is working on developing safe and effective medicines for children with HIV, teaming up with scientists and companies to create new treatments that can help kids stay healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Advanced Bioscience Laboratories, INC. NIH-funded |
| Lab location | 1 site (Kensington, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2030 |
| Funding year | 2023 |
| Award (this year) | $408,668 |
| NIH project number | 75N93023D00001-0-759302300003-1 |
| Project ID | NIH-10927009 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include children aged 0-21 who are living with HIV or are at risk of HIV infection.
✕Less likely to help
Patients who are not within the pediatric age range or those without any risk factors for HIV may not benefit from this research.
What this research studies
This research focuses on creating effective drug formulations specifically designed for children, particularly those affected by HIV. It aims to support the development of new therapeutics and prevention products through collaboration with various scientific and private sector partners. By providing essential research materials and preclinical development support, the project seeks to advance promising products into clinical testing, ensuring they are safe and effective for pediatric use.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and preventive measures for children living with or at risk of HIV.
How similar studies have gone: Previous research has shown success in developing pediatric formulations for other conditions, indicating potential for similar advancements in HIV treatment.
Where this research is happening
-
Advanced Bioscience Laboratories, INC.
Kensington, United States Active
Researchers
- Principal investigator: Silvera, Peter — Advanced Bioscience Laboratories, INC.
- Study coordinator: Silvera, Peter
Related research
Other NIH-funded projects on the same topics.
-
Development of vaccines and biologics for infectious diseases
This study is working on creating new vaccines to help protect people from infectious diseases, and it aims to make sure these vaccines are safe and effective before they are approved for use.
-
Developing new vaccines and biologics for infectious diseases
This study is all about creating and improving vaccines to help protect people from tough infections, including those that are hard to treat and could be used in bioterrorism, so that patients can have better options for staying healthy.
-
Developing a vaccine to fight fungal infections
This study is working on a new vaccine to help protect people, especially those with weakened immune systems, from serious fungal infections like Candida auris and Cryptococcus neoformans, which can be tough to treat.
-
Identifying and testing a new antibody treatment for Duchenne Muscular Dystrophy.
This study is looking at a new treatment for Duchenne Muscular Dystrophy (DMD) using a special type of antibody, and it aims to make sure the drug is safe and works well before it can be tested in people like you.
-
Developing and testing new oligonucleotides for medical use
This study is working on creating new types of medicines that target specific genes, which could lead to better treatments for patients with various health conditions.
-
Manufacturing a new treatment for pain management
This study is exploring a new way to help manage pain using a special compound called VHCA8*, and it's designed for people looking for better pain relief options that are safe and backed by science.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.